Zepbound vs Wegovy: which works better and which is easier to get online?

Short answer

• Which works better: On average, tirzepatide (Zepbound) produces larger weight losses in clinical trials than semaglutide 2.4 mg (Wegovy). Individual results vary, though — some people do very well on either drug.
• Which is easier to get online: Wegovy has been on the market longer and is more widely prescribed through telehealth programs, so it’s generally easier to arrange online. Zepbound (a newer approval for weight loss) can be harder to access at first and may require specialty-pharmacy handling or more insurer prior authorization.

Why (brief evidence and caveats)

• Efficacy: Clinical trial programs showed average percent weight loss higher with tirzepatide than with semaglutide (trials of tirzepatide reported mean losses in the high teens to low‑20s percent range for the highest doses; semaglutide trials reported mean losses roughly in the mid‑teens). That’s a trial-average difference — your personal response may differ.
• Side effects & safety: Both are GLP‑1/GIP‑related injectable drugs with similar common side effects (nausea, vomiting, diarrhea, constipation). Both have similar class warnings (e.g., avoid in pregnancy; personal/family history of medullary thyroid cancer or MEN2 is a contraindication). Tirzepatide may cause somewhat more or different GI effects in some people. Discuss risks with a prescriber.
• Metabolic context: If you have type 2 diabetes, dose/choice and glucose effects matter — tirzepatide has strong glucose‑lowering effects; close monitoring is needed if you’re on diabetes meds.

Access and cost practicalities

• Prescription required: Both need a prescription. Many telehealth services will evaluate you and can prescribe if appropriate, but insurers often require prior authorization and coverage varies.
• Availability: Because Wegovy has been on the market longer, more clinics and pharmacies are set up to prescribe and dispense it. Zepbound being newer may have more limited distribution early on and higher demand may cause supply issues.
• Cost: Out‑of‑pocket cost is often high for both unless your insurer covers it. Manufacturer savings cards, coupons, or copay programs sometimes help (check Novo Nordisk for Wegovy and Lilly for Zepbound). GoodRx and pharmacy discount cards can lower cash price for some formulations.

Where to look online (services that commonly handle GLP‑1 weight‑loss prescriptions)

• PlushCare — telehealth visits with board‑certified clinicians; they help with prescriptions and prior authorization.
• Hims & Hers (Hims) — consumer-facing telehealth weight‑loss programs that can arrange clinician visits and prescriptions.
• Ro (formerly Roman/Zero) — offers weight management telehealth and connects patients to prescribers for GLP‑1s.
• GoodRx Care / HeyDoctor — convenient telehealth visits plus GoodRx coupons to reduce costs.
• Local obesity medicine clinics or endocrinologists — often the best choice if you have complex medical history, diabetes, or want specialist care.

How to proceed

1. Talk with your primary care provider or a telehealth clinician about goals, medical history, and which drug fits you best.
2. Check insurance coverage and manufacturer savings programs up front (prior authorization is common).
3. If you prefer online care, pick one of the telehealth services above and ask specifically whether they can prescribe Wegovy or Zepbound (or tirzepatide if they still use Mounjaro off‑label) and whether they work with your insurer or specialty pharmacies.

If you want, tell me:

• whether you have diabetes or other medical conditions, and
• whether you prefer in‑person or telehealth care,

and I can help you narrow the best option and find telehealth providers that currently list Wegovy or Zepbound on their prescribing menus.